Singapore, Singapore

Chee Wai Chan

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Life Technologies Corporation, Life Technologies Holdings Pte Limited. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Chee Wai Chan

Introduction

Chee Wai Chan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly with his innovative work on electroporation technology. His dedication to advancing scientific research is evident through his patent and collaborations with leading companies in the industry.

Latest Patents

Chee Wai Chan holds a patent for an electroporation pipette. This invention is designed to enhance the efficiency of electroporation techniques, which are crucial for various applications in molecular biology and genetic engineering. His patent reflects his commitment to improving laboratory tools and methodologies.

Career Highlights

Throughout his career, Chee Wai Chan has worked with prominent organizations such as Life Technologies Corporation and Life Technologies Holdings Pte Limited. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Chee Wai Chan has collaborated with talented individuals in his field, including Mikko Makinen and See Chen Goh. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

In summary, Chee Wai Chan is a distinguished inventor whose work in electroporation technology has made a significant impact in the biotechnology sector. His patent and collaborations highlight his dedication to innovation and scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…